Medico Remedies Limited Stock Price Today (NSE: MEDICO)
Fundamental Score
Medico Remedies Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Medico Remedies Limited share price today is ₹35.42, down 0.06% on NSE/BSE as of 10 September 2026. Medico Remedies Limited (MEDICO) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹293.93 (Cr). The 52-week high for MEDICO share price is ₹56.88 and the 52-week low is ₹30.22. At a P/E ratio of 21.21x, MEDICO is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 19.04% and a debt-to-equity ratio of 0.25.
Medico Remedies Limited Share Price Chart — NSE/BSE Historical Performance
Medico Remedies Limited share price chart: -14.79% return over the past month. 52-week high ₹56.88, 52-week low ₹30.22.
Medico Remedies Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹39.23 | ₹39.24 | ₹34.11 | ₹35.44 | 23.83L (Cr) | |
| ₹41.11 | ₹41.11 | ₹39.03 | ₹39.28 | 2.01L (Cr) | |
| ₹39.87 | ₹41.10 | ₹39.49 | ₹40.77 | 1.06L (Cr) | |
| ₹39.40 | ₹40.19 | ₹39.00 | ₹39.87 | 52.93K (Cr) | |
| ₹39.23 | ₹40.30 | ₹39.11 | ₹39.50 | 60.84K (Cr) | |
| ₹38.35 | ₹43.00 | ₹37.50 | ₹39.33 | 7.45L (Cr) | |
| ₹42.60 | ₹42.70 | ₹36.90 | ₹38.91 | 10.17L (Cr) | |
| ₹42.59 | ₹42.59 | ₹41.50 | ₹42.35 | 2.20L (Cr) | |
| ₹43.62 | ₹43.62 | ₹42.00 | ₹42.41 | 1.67L (Cr) | |
| ₹42.37 | ₹43.70 | ₹41.50 | ₹43.31 | 1.47L (Cr) |
Medico Remedies Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹42.60 | ₹43.00 | ₹34.11 | ₹35.44 | -16.81% | |
| ₹49.70 | ₹51.49 | ₹41.12 | ₹42.35 | -14.79% | |
| ₹39.00 | ₹49.50 | ₹37.50 | ₹48.87 | +25.31% | |
| ₹47.17 | ₹50.90 | ₹36.55 | ₹38.61 | -18.15% | |
| ₹41.10 | ₹50.00 | ₹39.12 | ₹47.67 | +15.99% | |
| ₹32.95 | ₹43.00 | ₹32.95 | ₹42.48 | +28.92% | |
| ₹41.10 | ₹45.00 | ₹30.22 | ₹32.76 | -20.29% | |
| ₹49.03 | ₹51.00 | ₹43.91 | ₹44.53 | -9.18% | |
| ₹50.92 | ₹54.24 | ₹44.32 | ₹50.88 | -0.08% | |
| ₹53.15 | ₹56.88 | ₹48.50 | ₹50.60 | -4.80% | |
| ₹49.37 | ₹54.30 | ₹46.87 | ₹52.11 | +5.55% | |
| ₹48.48 | ₹53.00 | ₹46.05 | ₹50.45 | +4.06% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Medico Remedies Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Medico Remedies Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MEDICO across key market metrics for learning purposes.
Positive Indicators
12 factors identified
Strong Return on Equity (19.04%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (28.70%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 21.21 vs Industry: 34.89)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (38.49%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (81.43%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Excellent EPS Growth (38.27% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (38.33% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.25)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (11.00x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 1.66)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (61.38%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Limited Institutional Interest (FII+DII: 0.03%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Medico Remedies Limited vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Medico Remedies Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Medico Remedies LimitedMedico Remedies...Selected✓ MEDICO • 540937 | 70.2/100 | ₹35.42₹35 | ₹293.93₹293.93 | 21.21Average 21.2 Average | 19.04%Good 19.04% Good | 28.70%Excellent 28.70% Excellent | 0.25Excellent 0.2 Excellent | 38.33%Excellent 38.33% Excellent | 11.02%Good 11.02% Good | 0.00% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1876.50₹1877 | ₹450228.65₹450228.65 | 37.23Average 37.2 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9467.50₹9468 | ₹250888.75₹250888.75 | 85.90Average 85.9 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4939.50₹4940 | ₹167182.32₹167182.32 | 78.91Average 78.9 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1138.70₹1139 | ₹113642.26₹113642.26 | 25.38Average 25.4 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1371.90₹1372 | ₹110828.94₹110828.94 | 32.87Average 32.9 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1941.10₹1941 | ₹104867.93₹104867.93 | 95.81Average 95.8 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1683.00₹1683 | ₹96839.82₹96839.82 | 26.30Average 26.3 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2100.70₹2101 | ₹96054.51₹96054.51 | 17.36Average 17.4 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1144.50₹1145 | ₹95565.75₹95565.75 | 29.58Average 29.6 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2293.70₹2294 | ₹94729.81₹94729.81 | 46.35Average 46.3 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price450228.65 Cr
- Divi's Laboratories Limited share price250888.75 Cr
- Torrent Pharmaceuticals Limited share price167182.32 Cr
- Zydus Lifesciences Limited share price113642.26 Cr
- Cipla Limited share price110828.94 Cr
Medico Remedies Limited PE Ratio History
Historical price-to-earnings ratio for MEDICO — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹1.22 | ₹50.60 | 41.5x |
| FY 2024 | ₹1.00 | ₹54.95 | 55x |
| FY 2023 | ₹0.87 | ₹83.80 | 96.3x |
| FY 2022 | ₹0.58 | ₹65.17 | 112.4x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Medico Remedies Limited Quarterly Performance
Latest quarterly metrics for MEDICO — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
81.43%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
38.49%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
11.02%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
38.33%
Compounded annual net profit growth over 5 years
Medico Remedies Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for MEDICO — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Medico Remedies Limited Financial Statements
Annual income statement, balance sheet and cash flow for Medico Remedies Limited (MEDICO) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Medico Remedies Limited
About MEDICO (Medico Remedies Limited)
Medico Remedies Ltd is a dynamic pharmaceutical company deeply rooted in the Indian healthcare landscape. It distinguishes itself through a multifaceted approach, spanning the enti...re value chain from meticulous product development to state-of-the-art manufacturing and strategic marketing. The company is driven by a commitment to improving patient well-being, evidenced by its consistent efforts to formulate effective and accessible pharmaceutical solutions. Operating with unwavering ethical standards, Medico Remedies cultivates strong relationships with healthcare professionals and distribution partners. This dedication to quality and reliability has earned them a trusted reputation within the pharmaceutical sector. They are continually striving to expand their portfolio, incorporating innovative therapies while maintaining a steadfast focus on affordability and accessibility for the Indian population. The company's diverse product portfolio reflects its comprehensive approach to healthcare. It encompasses a wide range of therapeutic categories, including treatments for prevalent conditions such as infections, cardiovascular ailments, and diabetes. They offer an extensive range of anti-infectives addressing bacterial, fungal, and parasitic infections. Complementing these are a variety of medicines targeting common ailments, such as pain relief, fever reduction, and digestive issues. Their dedication to holistic wellness extends to the development and distribution of essential vitamins and supplements, promoting preventative care and overall health. Medico Remedies also addresses neurological and mental health concerns through their line of antidepressants, antipsychotics and anti-epileptics. This comprehensive approach demonstrates their commitment to fulfilling diverse healthcare needs within the Indian market. Medico Remedies employs cutting-edge manufacturing processes to produce high-quality pharmaceutical formulations. Their modern facilities adhere to stringent quality control standards, ensuring that every product meets the highest levels of safety and efficacy. Their distribution network is strategically designed to reach both urban and rural areas across India, making their medicines accessible to a broad spectrum of the population. The company invests significantly in research and development, continuously exploring new therapeutic avenues and striving to improve existing formulations. They operate with a clear vision: to be a leading provider of reliable and affordable healthcare solutions, empowering individuals to lead healthier and more fulfilling lives.
Company Details
Key Leadership
MEDICO Share Price: Frequently Asked Questions
What is the current share price of Medico Remedies Limited?
Medico Remedies Limited (MEDICO) trades at ₹35.42 on NSE and BSE. Market cap ₹293.93 (Cr). Educational data only.
What is the P/E ratio of Medico Remedies Limited?
Medico Remedies Limited has a P/E of 21.21x vs industry average 34.89x.
What is the Bull Run score for Medico Remedies Limited?
Medico Remedies Limited has a Bull Run score of 70.2/100 based on 25+ financial parameters.
Does Medico Remedies Limited pay dividends?
Medico Remedies Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Medico Remedies Limited?
Medico Remedies Limited has ROE of 19.04%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Medico Remedies Limited?
Medico Remedies Limited has debt-to-equity of 0.25.
Is Medico Remedies Limited a good investment?
Bull Run gives Medico Remedies Limited a score of 70.2/100. This is not investment advice — consult a SEBI-registered advisor.